Mark Warne

Chief Executive Officer at DEEPMATTER GROUP PLC

Net worth: 27 247 $ as of 2026-06-29

51 year

71 connections

Commercial Services

Health Technology

Technology Services

Profile

Mark Robert Warne is Chief Executive Officer & Executive Director at ChemAI Ltd. since 2018, Non-Executive Chairman at Ixico Plc since 2016, Healthcare Portfolio Director at IP Group Plc, Non-Executive Director at hVIVO Services Ltd. since 2016, Director at DegraSense Ltd., Director at Genomics Ltd., Member of The Royal Society of Chemistry, and Advisor at Angelini Ventures SpA. Former roles include Chief Executive Officer & Director at Activiomics Ltd. from 2011 to 2013, Director at Azellon Ltd., Non-Executive Director at hVIVO Holdings Ltd., Managing Director at Receptor Research Ltd., Director at Capsant Neurotechnologies Ltd., Non-Executive Director at Crysalin Ltd., Director at Iksuda Therapeutics Ltd., Director at Ubiquigent Ltd., Non-Executive Director at Optimal Medicine Ltd., Independent Non-Executive Director at hVIVO PLC in 2020, and Head-Life Science Division at IP Group Plc.
Education includes undergraduate, graduate, and doctorate degrees from the University of Bristol.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
IXICO PLC 0.11%	2026-07-14	247,341 ( 0.11% )	27 247 $	2026-06-29

Mark Warne active positions

Companies	Position	Start
DEEPMATTER GROUP PLC	Chief Executive Officer	2018-07-01
IXICO PLC	Chairman	-
Angelini Ventures SpA Angelini Ventures SpA Investment ManagersFinance Angelini Ventures invests in companies located in North America, Europe, Israel and Italy. The firm focuses on digital healthcare, connected medical devices and life sciences. It participates in early stage capital requirements.	Consultant / Advisor	-
hVIVO Services Ltd. hVIVO Services Ltd. Internet Software/ServicesTechnology Services Operates a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases	Director/Board Member	2016-03-31
Genomics Plc Genomics Plc BiotechnologyHealth Technology Develops research and experimental development on biotechnology	Director/Board Member	-
DegraSense Ltd.	Director/Board Member	-
The Royal Society of Chemistry The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences	Corporate Officer/Principal	2011-03-15
IP Group Plc /Venture Capital/ IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group invests in companies located in the United Kingdom, United States and Australia. The firm targets companies operating in the fileds of life sciences, deeptech and cleantech. It provides financing for early stage capital requirements.	Private Equity Investor	-

All active positions of Mark Warne

Former positions of Mark Warne

Companies	Position	End
HVIVO PLC	Director/Board Member	2020-12-30
░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	-
░░░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	-
░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	-
░░░░░░░ ░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	-

See the detail of Mark Warne's experience

Training of Mark Warne

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Warne's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	20
hVIVO Holdings Ltd. hVIVO Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Provides medical research services	Commercial Services
Ixico Plc Ixico Plc Miscellaneous Commercial ServicesCommercial Services Operates as a medical imaging company that provides imaging biomarkers for clinical trials, research studies and diagnostics	Commercial Services
IP Group Plc IP Group Plc Miscellaneous Commercial ServicesCommercial Services Operates as an intellectual property commercialization and venture capital fund management company	Commercial Services
Receptor Research Ltd. Receptor Research Ltd. Chemicals: Major DiversifiedProcess Industries Provides drug discovery informatics products and services	Process Industries
The Royal Society of Chemistry The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services Professional organization for the chemical sciences	Commercial Services
University of Bristol University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Capsant Neurotechnologies Ltd. Capsant Neurotechnologies Ltd. Pharmaceuticals: MajorHealth Technology Provides pre-clinical assay services to the drug development industry	Health Technology
DeepMatter Group Plc DeepMatter Group Plc Packaged SoftwareTechnology Services Develops AI-powered predictive chemistry solutions	Technology Services
Azellon Ltd. Azellon Ltd. Miscellaneous Commercial ServicesCommercial Services Develops stem cell therapy for the repair of avascular meniscal tears	Commercial Services
Crysalin Ltd. Crysalin Ltd. BiotechnologyHealth Technology Develops technology for protein structure determination	Health Technology
Iksuda Therapeutics Ltd. Iksuda Therapeutics Ltd. BiotechnologyHealth Technology Provides clinical development services for antibody-drug conjugate	Health Technology
Activiomics Ltd. Activiomics Ltd. Miscellaneous Commercial ServicesCommercial Services Provides high value information for the pharmaceutical and biotechnology industry	Commercial Services
hVIVO Services Ltd. hVIVO Services Ltd. Internet Software/ServicesTechnology Services Operates a human-based clinical trial platform to accelerate drug and vaccine development in respiratory and infectious diseases	Technology Services
IP Group Plc /Venture Capital/ IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group invests in companies located in the United Kingdom, United States and Australia. The firm targets companies operating in the fileds of life sciences, deeptech and cleantech. It provides financing for early stage capital requirements.	Finance
DegraSense Ltd.
Ubiquigent Ltd. Ubiquigent Ltd. Miscellaneous Commercial ServicesCommercial Services Develops reagents, kits, drug discovery assay development and compound profiling services	Commercial Services
Optimal Medicine Ltd. Optimal Medicine Ltd. Packaged SoftwareTechnology Services Offers individualized clinical decision support software for mental health disorders	Technology Services
Genomics Plc Genomics Plc BiotechnologyHealth Technology Develops research and experimental development on biotechnology	Health Technology
hVIVO PLC hVIVO PLC Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical development services	Commercial Services
Angelini Ventures SpA Angelini Ventures SpA Investment ManagersFinance Angelini Ventures invests in companies located in North America, Europe, Israel and Italy. The firm focuses on digital healthcare, connected medical devices and life sciences. It participates in early stage capital requirements.	Finance